Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VPM1002 vs BCG in HIV-exposed and unexposed infants
NCT02391415Phase 2Completed
- Sponsor
- Serum Institute of India
- Start
- Jun 2015
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
A Phase 2 trial of VPM1002 in Tuberculosis (TB), sponsored by Serum Institute of India. Started Jun 2015; status: completed.
02
Drugs
VPM1002
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02391415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391415.